Rice Blast Resistance Screening and Gene Deployment Automation Workflow

Manual screening and analysis of germplasm against diverse blast pathogen races can take 6-9 months per cycle. A custom automation workflow orchestrates high-throughput genomic marker analysis, GWAS for novel QTLs, and phenotype data fusion in parallel, compressing this to 2-4 months. This acceleration comes from eliminating manual data wrangling, script execution, and sequential analysis steps, allowing 2-3x more selection cycles per year.

Without automated QC and targeted screening, up to 30% of lab resources are spent on low-potential germplasm or contaminated samples. This workflow uses agents to validate raw sequence data, flag sample issues, and pre-screen germplasm using known Pi gene markers before committing to full phenotyping. This precise funneling reduces unnecessary pathogen assays, reagent costs, and sequencing runs, directly improving R&D operating margins.

Manual correlation of pathogen prevalence data with germplasm resistance profiles is slow and error-prone. The automated workflow ingests regional pathogen surveillance data, runs association analyses against the screened germplasm, and recommends the optimal resistance gene stacks for specific geographies. This data-driven targeting increases the probability of field success for new varieties, protecting yield and reducing product failure risk in key markets.

Manual processes limit screening to hundreds of lines. An automated, cloud-orchestrated workflow (using tools like Nextflow, Snakemake, or LangGraph for agent coordination) can process tens of thousands of samples by dynamically allocating HPC/cloud resources. The architecture manages compute costs, handles job failures, and consolidates results, turning genomic screening from a bottleneck into a scalable, on-demand service for the breeding program.

Manual compilation of data for patent filings (Freedom-to-Operate) and regulatory dossiers is a major administrative burden. This workflow automates the generation of evidence packages, linking discovered alleles to prior art in patent databases and structuring required phenotypic and genomic data for submissions. This reduces legal and compliance overhead by months, accelerating time-to-market and securing IP position for novel resistance traits.

Traditional R&D operates in siloed phases. This workflow builds a continuous feedback loop by automatically validating selection decisions. It compares predicted resistance from genomic models against actual field trial outcomes, monitoring for model drift and performance gaps. This data is used to retrain predictive models (e.g., Genomic Selection), creating a self-improving system that increases the accuracy and ROI of the resilience breeding pipeline over time.

Automates the ingestion and harmonization of raw data from screening facilities (disease scores, lesion types) and genotyping labs (SNP arrays, sequence-based markers for known Pi genes). Agents validate data quality, map samples to germplasm IDs in the breeding database (e.g., BreedBase, LIMS), and flag inconsistencies for review before analysis. This eliminates manual file handling and ensures a clean, analysis-ready dataset for thousands of lines.

A fault-tolerant agent orchestrates genome-wide association studies (GWAS) across diverse pathogen races, running mixed linear models to identify novel quantitative trait loci (QTLs) associated with blast resistance. It manages cloud/HPC resources (e.g., AWS Batch, SLURM), handles job failures, and annotates significant hits with genomic context. This turns a weeks-long, manual statistical process into a repeatable, high-throughput operation for discovering new resistance sources.

Integrates external pathogen surveillance data and internal race typing results to model the regional prevalence of specific blast races. An agent scores the predicted efficacy of known Pi genes and novel QTLs against these regional profiles, creating a dynamic deployment risk score. This shifts gene selection from a static checklist to a data-driven, geography-specific strategy for durable resistance.

Automates the simulation of crossing schemes to pyramid (stack) multiple resistance genes into elite breeding lines. An agent queries the pedigree and genomic database, evaluates genetic backgrounds, and recommends optimal parental combinations that maximize resistance coverage while managing genetic diversity and avoiding linkage drag. This replaces spreadsheet-based planning with scalable, computational optimization.

Orchestrates the application of molecular markers for foreground selection of target genes and background recovery of the elite genome. Upon receiving genotyping data, agents automatically apply predefined marker sets, advance or reject individuals in the breeding management system, and generate pick lists for the nursery. This ensures error-free, high-throughput application of MAS, accelerating the introgression of resistance genes.

A final agent synthesizes all analyses—gene efficacy scores, stacking plans, and regional pathogen models—into actionable deployment recommendations and regulatory-ready reports. It generates technical data sheets for commercial teams and updates the internal biological knowledge graph with new gene-trait-pathogen relationships, creating a closed-loop learning system for the breeding program.